Tech Company Financing Transactions
Radiance Therapeutics Funding Round
Radiance Therapeutics closed a $1 million funding round on 8/1/2018. Investors included private investors.
Transaction Overview
Company Name
Announced On
8/1/2018
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The investment will be used to fund development of the Company's Beta Ophthalmic System for delivery of beta irradiation therapy to improve glaucoma surgery outcomes.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
7440 N. Oracle Rd. Bldg. 1
Tucson, AZ 85704
USA
Tucson, AZ 85704
USA
Phone
Undisclosed
Website
Email Address
Overview
TxRadianceTx is a trademark of Radiance Therapeutics, Inc., a Delaware corporation. Radiance Therapeutics, Inc., a leader in ophthalmic therapeutic innovation, is commercializing a clinically demonstrated novel anti-metabolite therapy for glaucoma drainage surgery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laurence Marsteller
Browse more venture capital transactions:
Prev: 8/1/2018: Freshworks venture capital transaction
Next: 8/1/2018: Skyline AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs